Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Spotlight on cell therapy for Parkinson's disease

Dec. 4, 2001

Novel compounds for CNS disorders, including stroke and ALS

Dec. 3, 2001

FDA marketing approval granted for improved form of Ritalin for ADHD

Dec. 3, 2001

Cell death inhibitors under investigation by Sagami

Nov. 30, 2001

Japanese patent covers Suntory's new nicotinic acetylcholine receptor agonists

Nov. 30, 2001

Novel glutamate AMPA receptor antagonist may have potential in ALS

Nov. 30, 2001

Human umbilical cord blood cells in the treatment of stroke

Nov. 30, 2001

Phase I trial initiated for nasal administration of interferon beta

Nov. 30, 2001

Angiotech to expand phase II study of Paxceed for secondary progressive multiple sclerosis

Nov. 30, 2001

Potential analgesic alternative to morphine with low abuse potential -- HS-599

Nov. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...